Skip to content
AnalystLens

Omega Healthcare Investors Annual Report, Year Ended Dec 31, 2018

Filing Date
Filed February 26, 2019
Period End
December 31, 2018
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 10-K filed February 26, 2019. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. (Omega) is a REIT that provides financing and capital to the long-term healthcare industry, with a focus on skilled nursing facilities (SNFs).

At December 31, 2018, its portfolio included 924 healthcare facilities in 41 states and the U.K., operated by 68 third-party operators, with investments in these facilities of approximately $8.6 billiona and other investments of approximately $504.6 million. Total operating revenues for 2018 were $881.7 million, down from $908.4 million in 2017, while net income rose to $293.9 million from $104.9 million, reflecting lower impairments and the 2017 impairment losses of $297 million noted in the filing. Nareit FFO was $587.4 million in 2018 versus $444.3 million in 2017.

The company's near-term focus includes the pending acquisition of MedEquities Realty Trust, Inc., announced January 2, 2019, with total consideration of approximately $600 millionb including assumed debt. Each MedEquities share would convert into 0.235 of an Omega share plus $2.00 in cash. The merger is expected to close in the first half of 2019.

The filing also describes ongoing stress at certain operators, most notably Orianna Health Systems, which filed for Chapter 11 in March 2018, and the Daybreak rent deferrals. Omega received $78.8 millionc from the Orianna distribution trust in February 2019 and expects further payments.

Key risks for investors include operator credit quality, reimbursement changes under Medicare and Medicaid, Texas exposure (which increases after the MedEquities merger), a pending securities class action and related derivative suits, and the merger's conditions and potential dilution. Omega paid dividends of $528.7 milliond in 2018 and declared a quarterly common dividend of $0.66 per share, consistent with the prior three quarters.

Key Highlights

  1. Total operating revenues of $881.7 million in 2018, down from $908.4 million in 2017; rental income was $767.3 million.
  2. Net income of $293.9 million in 2018 versus $104.9 million in 2017; diluted EPS of $1.40 versus $0.51.
  3. Nareit FFO of $587.4 million in 2018 compared with $444.3 million in 2017.
  4. Portfolio of 924 healthcare facilities in 41 states and the U.K., operated by 68 third-party operators, with real estate investments of approximately $8.6 billion.
  5. Agreed on January 2, 2019 to acquire MedEquities Realty Trust for total consideration of about $600 million including assumed debt; expected to close in the first half of 2019.
  6. Orianna Health Systems' Chapter 11 remains a major issue: the remaining 15 SNFs were sold for $176 million in January 2019, and Omega received $78.8 million from the distribution trust on February 13, 2019.
  7. Ongoing securities class action and derivative litigation, with the Board concluding that litigation against current or former officers and directors is not in the company's best interests.

Financial Statements

FY2018 against FY2017

Line itemFY2018FY2017Change
Revenue$881.68M$908.38M−2.9%
Operating Expenses$610.29M$647.12M−5.7%
Operating Income$497.59M$315.17M+57.9%
Interest Expense$192.46M$188.76M+2.0%
Net Income$281.58M$100.42M+180.4%
EPS (Basic)$1.41$0.51+176.5%
EPS (Diluted)$1.40$0.51+174.5%
Shares Outstanding (Basic)200.28M197.74M+1.3%
Shares Outstanding (Diluted)209.71M206.79M+1.4%

Frequently Asked Questions

  1. What drove the change in net income between 2017 and 2018?

    Net income rose to $293.9 million in 2018 from $104.9 million in 2017. The filing attributes much of the change to lower impairments: impairments on real estate properties were $29.8 million in 2018 versus $99.1 million in 2017, and impairments on direct financing leases were $27.2 million versus $198.2 million. Gain on assets sold was $24.8 million in 2018 compared with $53.9 million in 2017.

  2. What is the MedEquities transaction and how is it structured?

    Omega agreed on January 2, 2019 to acquire MedEquities Realty Trust, Inc. Each MedEquities common share would convert into 0.235 of an Omega common share plus $2.00 in cash, with cash in lieu of fractional shares. The total consideration, including assumed debt, is approximately $600 million. MedEquities would also pay a pre-closing special dividend of $0.21 per share. The merger is subject to closing conditions including a MedEquities stockholder vote and is expected to close in the first half of 2019, with a termination right if not consummated by June 30, 2019.

  3. How is Omega exposed to operator credit risk?

    Omega's leases are triple-net and its operators bear property expenses, but the filing notes that operators may fail to meet obligations, especially during bankruptcy. Orianna filed Chapter 11 in March 2018 and was placed on a cash basis, with no income recognized from Orianna from July 1, 2017 through December 31, 2018. Daybreak fell behind on rent in the fourth quarter of 2018, and Omega agreed to defer rent in 2019. Omega's largest tenant, Ciena Healthcare, accounted for about 12% of the portfolio by investment.

  4. What are the main regulatory and reimbursement risks?

    The filing highlights Medicare and Medicaid reimbursement pressure. Key items include the shift to the Patient Driven Payment Model (PDPM) effective October 1, 2019, the 2% sequestration cuts extended through 2027, and state Medicaid budget pressure. Texas is a particular concern: Omega's exposure there is about 10% of investments, and the filing describes it as a difficult operating environment with low Medicaid rates, which will increase further after the MedEquities acquisition.

  5. What dividend did Omega pay and what is the outlook for distributions?

    Omega paid $528.7 million in common dividends in 2018 and declared $0.66 per share quarterly, totaling $2.64 for the year. In February 2019 the Board declared another $0.66 dividend, payable February 15, 2019. The filing states that future distributions depend on Board discretion, financial condition, liquidity, and REIT requirements, and that the company must distribute at least 90% of REIT taxable income.